Wave Life Sciences (WVE) EPS (Basic) (2014 - 2026)
Wave Life Sciences' (WVE) quarterly EPS (Basic) came in at -$0.34 in Q2 2026, down 10.46% YoY from -$0.38 in Q2 2025, and down 160.86% on a QoQ basis from -$0.13 in Q1 2026.
Powered by 
Analysis
Wave Life Sciences (WVE) EPS (Basic) (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of EPS (Basic) data on file, last reported at -$0.34 in Q2 2026.
- Quarterly EPS (Basic) fell 10.46% year-over-year to -$0.34 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$0.99 (down 25.32% YoY) and the FY2025 annual result came in at -$1.21, down 72.74% from the prior year.
- EPS (Basic) eased to -$0.34 in Q2 2026, from -$0.13 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.21 in Q4 2024 to a low of -$0.62 in Q1 2022.
- A 5-year average of -$0.29 and a median of -$0.3 in 2025 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 237.88% in 2024, down 779.2% in 2024.
- Tracing WVE's EPS (Basic) over 5 years: stood at -$0.55 in 2022, then surged by 72.32% to -$0.15 in 2023, then surged by 237.88% to $0.21 in 2024, then tumbled by 249.05% to -$0.32 in 2025, then retreated by 7.81% to -$0.34 in 2026.
- The last three EPS (Basic) figures came in at -$0.34 (Q2 2026), -$0.13 (Q1 2026), and -$0.32 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Wave Life Sciences | 988.42 Mn | 620.41 Mn | - | -0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.32 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.31 |
| Mar 31, 2025 | -0.29 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.15 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.27 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.42 |
| Jun 30, 2022 | -0.62 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -0.67 |
| Sep 30, 2021 | -0.12 |